Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Prostate Cancer

  Free Subscription

Articles published in Cancer Imaging

Retrieve available abstracts of 17 articles:
HTML format

Single Articles

    July 2021
  1. HE D, Wang X, Fu C, Wei X, et al
    MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
    Cancer Imaging. 2021;21:46.
    PubMed     Abstract available

    April 2021
  2. OSMAN MM, Iravani A, Hofman MS, Hicks RJ, et al
    Intra-patient comparison of physiologic (68)Ga-PSMA-11 and (18)F-DCFPyL PET/CT uptake in ganglia in prostate cancer patients: a pictorial essay.
    Cancer Imaging. 2021;21:35.
    PubMed     Abstract available

    January 2021
  3. VENKATESAN AM, Mudairu-Dawodu E, Duran C, Stafford RJ, et al
    Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade.
    Cancer Imaging. 2021;21:3.
    PubMed     Abstract available

    October 2020
  4. PRICOLO P, Ancona E, Summers P, Abreu-Gomez J, et al
    Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels.
    Cancer Imaging. 2020;20:77.
    PubMed     Abstract available

  5. HIETIKKO R, Kilpelainen TP, Kenttamies A, Ronkainen J, et al
    Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study.
    Cancer Imaging. 2020;20:72.
    PubMed     Abstract available

    August 2020
  6. DE LEIRIS N, Leenhardt J, Boussat B, Montemagno C, et al
    Does whole-body bone SPECT/CT provide additional diagnostic information over [18F]-FCH PET/CT for the detection of bone metastases in the setting of prostate cancer biochemical recurrence?
    Cancer Imaging. 2020;20:58.
    PubMed     Abstract available

    January 2020
  7. PETERSEN LJ, Zacho HD
    PSMA PET for primary lymph node staging of intermediate and high-risk prostate cancer: an expedited systematic review.
    Cancer Imaging. 2020;20:10.
    PubMed     Abstract available

    December 2019
  8. XU L, Zhang G, Shi B, Liu Y, et al
    Comparison of biparametric and multiparametric MRI in the diagnosis of prostate cancer.
    Cancer Imaging. 2019;19:90.
    PubMed     Abstract available

  9. RAHMAN LA, Rutagengwa D, Lin P, Lin M, et al
    High negative predictive value of 68Ga PSMA PET-CT for local lymph node metastases in high risk primary prostate cancer with histopathological correlation.
    Cancer Imaging. 2019;19:86.
    PubMed     Abstract available

  10. LI Q, Lu H, Choi J, Gage K, et al
    Radiological semantics discriminate clinically significant grade prostate cancer.
    Cancer Imaging. 2019;19:81.
    PubMed     Abstract available

    June 2019
  11. DAMJANOVIC J, Janssen JC, Prasad V, Diederichs G, et al
    (68)Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer.
    Cancer Imaging. 2019;19:37.
    PubMed     Abstract available

    May 2019
  12. LU YF, Zhang Q, Yao WG, Chen HY, et al
    Optimizing prostate cancer accumulating model: combined PI-RADS v2 with prostate specific antigen and its derivative data.
    Cancer Imaging. 2019;19:26.
    PubMed     Abstract available

  13. FERREIRA G, Iravani A, Hofman MS, Hicks RJ, et al
    Intra-individual comparison of (68)Ga-PSMA-11 and (18)F-DCFPyL normal-organ biodistribution.
    Cancer Imaging. 2019;19:23.
    PubMed     Abstract available

    November 2018
  14. KEIDAR Z, Gill R, Goshen E, Israel O, et al
    68Ga-PSMA PET/CT in prostate cancer patients - patterns of disease, benign findings and pitfalls.
    Cancer Imaging. 2018;18:39.
    PubMed     Abstract available

    May 2018
  15. DAMJANOVIC J, Janssen JC, Furth C, Diederichs G, et al
    (68) Ga-PSMA-PET/CT for the evaluation of pulmonary metastases and opacities in patients with prostate cancer.
    Cancer Imaging. 2018;18:20.
    PubMed     Abstract available

    December 2017
  16. IRAVANI A, Hofman MS, Mulcahy T, Williams S, et al
    (68)Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer.
    Cancer Imaging. 2017;17:31.
    PubMed     Abstract available

  17. WILL L, Giesel FL, Freitag MT, Berger AK, et al
    Integration of CT urography improves diagnostic confidence of (68)Ga-PSMA-11 PET/CT in prostate cancer patients.
    Cancer Imaging. 2017;17:30.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.